Corindus Envisions Network Of CorPath Robots For Remote Neurovascular And Coronary Interventions
The physician who led the first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
You may also be interested in...
Siemens Healthineers' acquisition of radiation oncology company Varian Medical Systems creates an oncology giant. Analysts disagree on whether its the right move for the companies.
The Siemens Healthineers subsidiary is planning to create networks of CorPath GRX robotic intervention systems that will expand patient access to urgent interventions and reduce radiation exposure for both the patient and interventionalists.
French company Robocath believes its R-One robotic catheter intervention system will make coronary interventions more efficient for hospitals and safer for interventionalists. Robocath is sponsoring a 60-patient European trial of coronary interventions with R-One.